本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

7.33
-0.1600-2.14%
盘后:7.330.00000.00%19:56 EDT
成交量:127.02万
成交额:941.86万
市值:10.89亿
市盈率:-6.76
高:7.55
开:7.41
低:7.25
收:7.49
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
数据加载中...
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”